Show
Sort by
-
Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis
-
The impact of the prostaglandin D₂ receptor 2 and its downstream effects on the pathophysiology of asthma
-
Tnfaip3 expression in pulmonary conventional type 1 Langerin‐expressing dendritic cells regulates T helper 2‐mediated airway inflammation in mice
-
Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma
-
Real-life assessment of chronic rhinosinusitis patients using mobile technology
-
Immunomodulatory properties of lolium perenne peptides for the treatment of seasonal allergic rhinitis
-
Baseline characteristics of phase 3 randomized controlled trials of omalizumab in chronic rhinosinusitis with nasal polyps
-
Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS- 24, SINUS- 52 phase 3 studies
-
Differentiating eosinophil and neutrophil inflammation in chronic rhinosinusitis with and without nasal polyps